Isebenza njani i-tirzepatide kunye ne-semaglutide?
Njengeenaliti ezithandwayo ze-weightloss, i-Semaglutide kunye ne-Tirzepatide zisebenza ngokunciphisa ukutya.Utshintsho kwindlela yokutya kunye nokuzivocavoca rhoqo zidibaniswa nala mayeza.
Semaglutideyi-glucagon-like peptide-1 (GLP-1) receptor agonist, nto leyo ethetha ukuba ilinganisa ihomoni ye-GLP-1 kwaye ikwenza ungaziva ulambile. yenza i-insulin eninzi.Inokuthumela imiqondiso epheleleyo engqondweni.
Tirzepatideikwabizwa ngokuba yiMounjaro.Zizo zombini i-glucose exhomekeke kwi-insulinotropic polypeptide (GIP) kunye ne-GLP-1 receptor agonist.I-Tirzepatide ilinganisa Umthombo othembekileyo wehomoni ye-GLP-1 kunye nehomoni ye-GIP.I-hormone ye-GIP inokubangela ukudala i-insulin kunye neemvakalelo zokuzala.
Iidosi kunye neziphumo?
Idosi iya kwahluka kwizigulane ezahlukeneyo.Landela imiyalelo kagqirha wakho okanye imiyalelo kwileyibhile.Olu lwazi lulandelayo lubandakanya kuphela iidosi eziqhelekileyo .Ukuba idosi yakho yahlukile, musa ukuyitshintsha ngaphandle kokuba ugqirha wakho akuxelele ukuba wenze njalo.
Iidosi zeTirzepatide
Umthamo wokuqala: 2.5 mg ngaphantsi kwesikhumba kanye ngeveki
Emva kweeveki ze-4: Umthamo kufuneka unyuswe kwi-5 mg ngaphantsi kwe-subcutaneously kanye ngeveki.
Ukulawulwa kwe-glycemic eyongezelelweyo: Ukwandisa umthamo kwi-2.5 mg increments emva ubuncinane kweeveki ze-4 kwi-dose yangoku.
Ubuninzi bedosi: 15 mg ngaphantsi kwesikhumba kanye ngeveki
I-Semaglutide 5mg
I-Methylcobalamin 0.2mg/mL
(2mL ubukhulu bebhotile)
• Iveki yoku-1 ukuya kwiveki yesi-4 : Tofa
Iiyunithi ze-5 (0.25mg / 0.05mL) kanye ngeveki
• Iveki yesi-5 ukuya kwiveki yesi-8: Tofa
Iiyunithi ezili-10 (0.5mg / 0.1mL) kanye ngeveki
• Iveki yesi-9 ukuya kwiveki ye-12: Tofa
Iiyunithi ze-20 (1mg / 0.2mL) kanye ngeveki
• Iveki ye-13 ukuya kwiveki ye-16: Tofa
Iiyunithi ezingama-34 (1.7mg/0.34mL) kanye ngeveki
• Iveki ye-17 ukuya phambili: Tofa iiyunithi ezingama-48
(2.4mg/0.48mL) kanye ngeveki
Ukusebenzisa i-tirzepatide kubangele ukulahlekelwa kwesisindo se-17.8% (95% CI: 16.3% -19.3%) xa kuthelekiswa ne-12.4% (95% CI: 11.5% -13.4%) ye-semaglutide.
Izigqibo: I-Tirzepatide inikeza ixabiso elingcono lemali kune-semaglutide yokunciphisa ubunzima.
IF Iindleko zeTirzepatidephezulu kunoIindleko zeSemgalutideKwaye yeyiphi edume ngakumbi e-USA nase-UK?
Enye i-peptide ye-Weightloss injection nceda ujonge
Ixesha lokuposa: Nov-18-2023